A Phase 3, Multicentre, Double-Masked, Randomised Study to Evaluate the Efficacy and Safety ofIntravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participantswith Neovascular Age-related Macular Degeneration (nAMD)

Project: Research project

Project Details

Description

A Phase 3, Multicentre, Double-Masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD)
StatusActive
Effective start/end date9/23/21 → 9/23/26

Funding

  • OPTHEA LTD

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint